Status:

COMPLETED

The Support, Educate, Empower (SEE) Program

Lead Sponsor:

University of Michigan

Collaborating Sponsors:

National Eye Institute (NEI)

Conditions:

Glaucoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will test whether the Support, Educate, Empower (SEE) personalized Glaucoma Coaching Program improves eye drop medication adherence among glaucoma patients compared to enhanced standard car...

Eligibility Criteria

Inclusion

  • Taking greater or equal to 1 ocular hypotensive medication with a diagnosis of any kind of glaucoma, suspected glaucoma or ocular hypertension
  • Did not opt-out from recruitment letter

Exclusion

  • Do not speak English
  • Have a diagnosed serious mental illness (for example, Schizophrenia)
  • Diagnosed cognitive impairment
  • Do not instill their own eye drops
  • Had laser or incisional glaucoma surgery within three months of enrollment or scheduled during the six-month study period
  • Unable to attend all study visits
  • Active ocular infection or uveitis

Key Trial Info

Start Date :

April 27 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2024

Estimated Enrollment :

236 Patients enrolled

Trial Details

Trial ID

NCT04735653

Start Date

April 27 2021

End Date

July 31 2024

Last Update

November 3 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Michigan

Ann Arbor, Michigan, United States, 48109

2

Henry Ford Hospital

Detroit, Michigan, United States, 48202